04/17/2020
COVID-19 - hyperbaric oxygen therapy
We may be looking at COVID-19 from the wrong angle.
Dr. Katz, Medical Director at Hyperbaric Medical Solutions explains that COVID-19 is currently being treated as a pneumonia, but should be treated as pure hypoxia, a condition in which the body is deprived of oxygen.
He further said the lungs are not failing and it’s not a ventilation problem, stating specifically that “the problem is the interface of alveoli, the lung sacs, and the blood’s ability to carry oxygen. That's where we need to focus.”
Dr. Katz continues to say, "hyperbaric oxygen increases the amount of oxygen carried in the blood stream and does not depend on hemoglobin. Additionally, it decreases the inflammatory cytokine storm we are seeing in COVID-19 patients. The hope would be that, in using hyperbaric oxygen therapy, we would be able to shut down an inflammatory response and reverse the need for ventilation.”
Dr. Katz would like to see more investigation with hyperbaric oxygen therapy—mainly because it can decrease inflammation and carry increased oxygen into the bloodstream, allowing more oxygen to perfuse deep tissue and organs. HBOT being used to treat disease isn't new. In 1918, HBOT was used to successfully treat the deadly Spanish flu.
Full interview link: https://www.hyperbaricmedicalsolutions.com/blog/hms-medical-director-discusses-hbot-solution-for-covid-19-on-la-based-radio-show?utm_source=hs_email&utm_medium=email&utm_content=86451942&_hsenc=p2ANqtz--K9S0L4NidYYDiZOiNeABmHGUsExDnShp60ENjRLwkRRGM0vxc6JYcBqtMf5h_88zk7dGFKi12GSAWMMH2XfT8nEjO2nzhzEaeWIEovlqqONxRM9E&_hsmi=86451942
http://baromedical.ca/medical-covid-19.php
Information on COVID-19 and how hyperbaric oxygen therapy may reduce mortality and requirements for mechanical ventilation.